✦ LIBER ✦

Efficacy of α-glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia

✍ Scribed by Professor W. LEONHARDT; M. HANEFELD; S. FISCHER; J. SCHULZE

Book ID: 114727384
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 377 KB
Volume: 24
Category: Article
ISSN: 0014-2972
DOI: 10.1111/j.1365-2362.1994.tb02256.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

α-Glucosidase inhibitors in diabetes: ef

α-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects

✍ Dr M. TOELLER 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Effect of two α-glucosidase inhibitors,

Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms

✍ Tomomi Fujisawa; Hiroshi Ikegami; Kaori Inoue; Yumiko Kawabata; Toshio Ogihara 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Effect of hydroxypropylmethylcellulose o

Effect of hydroxypropylmethylcellulose on serum lipids in subjects with mild-to-moderate primary hypercholesterolemia

✍ Davidson, M.H.; Maki, K.C.; Albrecht, H.H.; O'Mullane, J. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Improvement of insulin sensitivity and d

Improvement of insulin sensitivity and dyslipidemia with a new α-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects

✍ Kazuya Shinozaki; Masaaki Suzuki; Motoyoshi Ikebuchi; Junya Hirose; Yasushi Hara 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 662 KB

Prevention of Type 2 Diabetes || Decreas

Prevention of Type 2 Diabetes || Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial

✍ LeRoith, Derek 📂 Article 📅 2012 🏛 Springer New York 🌐 English ⚖ 597 KB

There Is A World-wide Epidemic On Obesity. This Epidemic Is Driving The Immense Proportions Of Type 2 Diabetes Across The Globe. While There Are Numerous Therapies For Treating Type 2 Diabetes, The Most Effective Therapy Is Prevention. Prevention Of Type 2 Diabetes Can Be Achieved Properly By Simult

The effect of the gastrointestinal lipas

The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia

✍ S. Tonstad; D. Pometta; D. W. Erkelens; L. Ose; T. Moccetti; J. A. Schouten; A. 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 610 KB

The effect of orlistat, a nonabsorbed inhibitor of gastric and pancreatic lipases, was examined in patients with primary hyperlipidaemia (serum cholesterol \_> 6.2 retool. 1-1 and triglycerides < 5.0 mmol-1-~) not responsive to dietary change alone, In a multicentre, randomised, double-blind study,